02 August 2012 08:32

EC raises concern at Visa Europe on credit card interchange fees

Visa Europe

European regulators have formally raised concerns that consumers could be paying too much because of fees charged by Visa to process cross-border credit card transactions.

The European Commission told Visa of its concerns about "possible violations of EU antitrust rules" relating to Visa's "multilateral interchange fees" (MIFs) system, which charges retailers for the transactions they handle. 

In a supplementary statement, the Commission says that its preliminary view is that the Visa multilateral interchange fees (MIFs) for consumer credit cards violate its rules designed to stop cartels and restrictive business practices.

The EC says it thinks that MIFs "harm competition between acquiring banks, inflate the cost of payment card acceptance for merchants and ultimately increase consumer prices".

It also "doubts" that Visa's MIFs are "necessary to create efficiencies that benefit merchants and consumers" and could therefore be entitled to an exception from the rules. 

The supplementary statement is the latest stage in a lengthy battle that saw Visa slash its multilateral interchange fees for debit cards in late 2010 but refuse to back down credit cards.

Visa can now make a written reply or ask for a hearing on the issue which could see fines imposed of up to 10% of turnover imposed for antitrust breaches,

Responding to the new development, Peter Ayliffe, CEO, Visa Europe, says: "We are very disappointed that the Commission has taken such a confrontational approach and was not willing to find a solution to support investment and innovation in European payments for the benefit of European consumers and to allow European payments to compete globally." 

In May an EU court dismissed Visa rival MasterCard's challenge against an EC ruling that the firm's cross-border interchange fees for both credit and debit cards violated competition law.

Meanwhile, both card giants are facing interchange problems in the US: having agreed a $7.25 billion class action settlement with retailers earlier this month, several major merchants, including Walmart, have now come out against the plan.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
16 Jul
TOPO
MÅ JEG ALLER FØRST MINDE OM. da jeg tog på fereie, var der en uvenlig sjæl som ønskede mig såkaldt "..
19
21 Jul
TOPO
Kurshop -  Der findes tusinder af Biotekfirmaer i verden som du kan gå ud og investerer i ! Hvad er ..
14
20 Jul
VELO
Sidder ig gennemlaser tidligere traade og samler her lidt op og vil komme med betragtninger for den ..
12
18 Jul
VWS
Pokerchamp - Du er da gået helt fra koncepterne. Din angreb på meddebatørene er da røget helt ud i h..
12
16 Jul
GEN
Nej problemet med EI er, at der ikke er mange dygtige skribenter (eksperter) tilbage ! Og hvad værre..
12
18 Jul
VWS
sku vi prøve med en afstemning,ang hvem der er mest ude i hampen Alle dem der hellre vil tro på good..
9
16 Jul
VWS
Så er i jo 2, hvis i tager pokerdrengen med så kunne i jo starte jeres eget cirkus fremfor at ødelæg..
9
15 Jul
VWS
Pokerchamp jeg ser ingen grund til at du overfalder mig på denne måde, har jeg generet eller gjordt ..
9
13:49
VWS
Mon dette forum og skribenterne mon nogensinde bliver så voksent, at vi er undgår dette evindelige b..
8
21 Jul
E:VWS
Du kan da umuligt fjerne kernemedarbejdere med 10-30 års erfaring når de ikke engang har haft fabrik..
8

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Publicis Groupe: First Half-Year 2014 Results
2
Wolters Kluwer Legal & Regulatory to Acquire LexisNexis Legal Business in Poland and Divest Canadian Legal Assets
3
HFF secures construction loan and joint venture equity for luxury Class AAA Uptown Dallas mixed-use development
4
Stryker Declares a $0.305 Quarterly Dividend
5
Oil States Announces Second Quarter 2014 Earnings Conference Call
Euroinvestor around the globe: Euroinvestor.dk | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 July 2014 20:16:18
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20140710.1 - EUROWEB1 - 2014-07-22 21:16:18 - 2014-07-22 20:16:18 - 1000 - Website: OKAY